Agensys
Specializes in therapeutic antibody research and development in cancer.
Launch date
Market cap
-
Enterprise valuation
€352m (Public information from Dec 2007)
Santa Monica California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $8.0m | Series A | |
$11.3m | Series B | ||
$42.8m | Series C | ||
$3.0m | Debt | ||
$41.3m | Series D | ||
$387m Valuation: $387m | Acquisition | ||
Total Funding | €94.0m |
Recent News about Agensys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.